Incb009471
http://www.cdek.liu.edu/trial/NCT00393120/ WebINCB009471 is a selective CCR5 antagonist for the treatment of HIV-1 infection in patients who harbor R5 tropic virus. INCB009471 metabolism is predominantly P450-mediated monohydroxylation and...
Incb009471
Did you know?
WebOct 21, 2024 · INCB009471 INCB9471 INCB-009471 INCB-9471 Drug Info: TTD ChemblDrugs ChemblInteractions (0 More Sources) Publications: INCB-9471 CCR5 … WebThis gene is one of several CC cytokine genes clustered on the p-arm of chromosome 9. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The protein encoded by this gene is chemotactic for skin-associated memory T lymphocytes.
WebA Randomized, Double-blind, Placebo-controlled Study Exploring the Safety, Tolerability, PK & Virological Effect of Once Daily Oral Dosing of INCB009471 as Monotherapy for 14 Days … WebBackground Information: INCB9471 Preclinical studies demonstrate: --Selective for CCR5 receptor --90% IC for R5-tropic viruses = 8-10 nM --Moderate plasma protein binding free fraction = 16% --Protein-binding adjusted IC90 = 50-60 nM --Additive/synergistic in vitro for other ARVs Single and multiple dose Phase 1 studies demonstrate:
WebThis study will evaluate the safety, pharmacokinetics and efficacy of the CCR5 antagonist INCB009471 in HIV-1 infected patients who are antiretroviral therapy naïve, or who are not … WebINCB009471 Single-Dose Plasma Concentrations (Mean ± SE) Source publication Single and Multiple Dose Pharmacokinetics of INCB9471, a Potent Single and Multiple Dose Pharmacokinetics of INCB9471,...
WebOct 26, 2006 · This study will evaluate the safety, pharmacokinetics and efficacy of the CCR5 antagonist INCB009471 in HIV-1 infected patients who are antiretroviral therapy …
WebDr. Peter Ruane earned his medical degree from University College Dublin and completed an internal medicine residency from the Mayo Clinic in Rochester, Minnesota. He completed a research and clinical fellowship in Infectious Diseases at the West Los Angeles Veterans Administration and is Board Certified in Infectious Diseases. b klasse service cWebThe CCR5 antagonist INCB009471 has nanomolar activity against HIV-1 in vitro. This compound demonstrated potent and prolonged antiviral activity against R5-tropic HIV-1 when given 200 mg once daily dose for 14 days. These findings supported further clinical development of INCB009471 and they have since progressed to phase IIb clinical trials. bklawesart.comWebβ-Thromboglobulin ( β-TG ), or beta-thromboglobulin, is a chemokine protein secreted by platelets. [1] [2] It is a type of chemokine (C-X-C motif) ligand 7. [3] Along with platelet factor 4 (PF4), β-TG is one of the best-characterized platelet-specific proteins. bk large iced coffeeWebDownload scientific diagram INCB009471 Single-Dose Plasma Concentrations (Mean ± SE) from publication: Single and Multiple Dose Pharmacokinetics of INCB9471, a Potent … bkl342lwhWebADP machines, nesoi, entered as a system (consisting of a central processing unit, an input unit, and an output unit) Processing units other than those of subheading 8471.41 and … b klasse thermostat wechselnWebThis study will evaluate the safety, pharmacokinetics and efficacy of the CCR5 antagonist INCB009471 in HIV-1 infected patients who are antiretroviral therapy naïve, or who are not … bklbwebcastWebscriptase inhibitor), vicriviroc and INCB009471 (CCR5 inhibitors) and elvitegravir (integrase inhibitor). The potential of other compounds with new modes of action is less clear. Currently, maturation inhibitors appear promising but for other drugs, obstacles to continued development, such as the need of parenteral application bkl builders corp